Garaci, E <br/><br/>
Antitumor effect of thymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha,beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleukemia cells.  [electronic resource] 

 -  Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy  Jan 1993 
 - 7-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1067-5582 
<br/><br/><label>Standard No.: </label>10.1097/00002371-199301000-00002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>CD4 Antigens--immunology<br/>CD8 Antigens--immunology<br/>Cyclophosphamide--administration & dosage<br/>Cytotoxicity, Immunologic--drug effects<br/>Disease Models, Animal<br/>Friend murine leukemia virus<br/>G(M1) Ganglioside--immunology<br/>Interferon-alpha--administration & dosage<br/>Interferon-beta--administration & dosage<br/>Interleukin-2--administration & dosage<br/>Leukemia, Erythroblastic, Acute--mortality<br/>Leukemia, Experimental--prevention & control<br/>Male<br/>Mice<br/>Mice, Inbred DBA<br/>Thymalfasin<br/>Thymosin--administration & dosage<br/>Tumor Virus Infections--prevention & control